<DOC>
	<DOCNO>NCT02971982</DOCNO>
	<brief_summary>Patients receive RCD PCD combination induction treatment follow rituximab velcade maintenance therapy , investigator try compare , good partial remission ( VGPR ) rate , complete remission ( CR ) rate , Overall remission rate ( MR+CR + VGPR + partial remission ( PR ) rate ) , major reaction rate ( MRR , PR+VGPR+CR ) end research .</brief_summary>
	<brief_title>PCD Versus RCD Treatment Patients With Waldenstrom 's Macroglobulinemia</brief_title>
	<detailed_description>This open-label , single-centre , randomised study , look series 40 patient age 75 newly diagnose Waldenstrom 's macroglobulinemia ( WM ) previously treat . Patients receive RCD PCD combination induction treatment follow rituximab velcade maintenance therapy , investigator try compare , good partial remission ( VGPR ) rate , complete remission ( CR ) rate , Overall remission rate ( MR+CR + VGPR + partial remission ( PR ) rate ) , major reaction rate ( MRR , PR+VGPR+CR ) end research .</detailed_description>
	<mesh_term>Waldenstrom Macroglobulinemia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Recently diagnose WM accord second 2002 WM international work group Not previously treat , apart regularly receive Chlorambucil Aged 18 75 year , male female Ability give sign informed consent Negative pregnancy test inclusion ( necessary ) ECOG 0 2 Known hypersensitivity rituximab velcade cyclophosphamide Uncontrolled infection include bacteria , virus fungus , include active HBV infection Organic dysfunction : Bilirubin &gt; 1.5 x normal , Renal failure require dialysis , glutamic pyruvic transaminase ( ALT ) GlutamicOxaloacetic Aminotransferase ( AST ) &gt; 2.5 x normal Positive HIV serology Serious psychiatric item history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>